The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Trusted for more than 20 years, HEMASHIELD grafts are the most used, most studied vascular products available in the market today. More than 2 million HEMASHIELD grafts have been implanted ...

LifeSpan ePTFE Vascular Grafts for peripheral vascular reconstructions and AV Access have been used in clinical practice for more than 15 years. It features soft ePTFE material with superb suture ...

Cite this: Technology Insight: The Evolution of Tissue-Engineered Vascular Grafts--From Research to Clinical Practice - Medscape - Jul 01, 2007. The recent transition to clinical use by two ...

Pluristyx has developed a clinical-grade manufacturing process for using a licensed Mad7 gene editing technology to block Human Leukocyte Antigen (HLA) markers expression. Humacyte is optimizing a ...

Humacyte announced it received full FDA approval for SYMVESS for use in adults as a a vascular conduit for ... today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief ...

"We are excited to grow our pipeline by advancing the development of the BVP, an advanced tissue and organ system,” said Laura Niklason ... other vascular applications, including arteriovenous (AV) ...